SG11201704430SA - Preventive and/or therapeutic agent of immune disease - Google Patents
Preventive and/or therapeutic agent of immune diseaseInfo
- Publication number
- SG11201704430SA SG11201704430SA SG11201704430SA SG11201704430SA SG11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA
- Authority
- SG
- Singapore
- Prior art keywords
- preventive
- therapeutic agent
- immune disease
- immune
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015017386 | 2015-01-30 | ||
PCT/JP2016/052732 WO2016121953A1 (en) | 2015-01-30 | 2016-01-29 | Prophylactic and/or therapeutic agent for immune diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201704430SA true SG11201704430SA (en) | 2017-08-30 |
Family
ID=56543555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201704430SA SG11201704430SA (en) | 2015-01-30 | 2016-01-29 | Preventive and/or therapeutic agent of immune disease |
Country Status (21)
Country | Link |
---|---|
US (1) | US9782412B2 (en) |
EP (1) | EP3120852B1 (en) |
JP (1) | JP6093485B2 (en) |
KR (1) | KR101858421B1 (en) |
CN (2) | CN113768935A (en) |
AU (1) | AU2016213030B2 (en) |
BR (1) | BR112017016278B1 (en) |
CA (1) | CA2975372C (en) |
DK (1) | DK3120852T3 (en) |
ES (1) | ES2734364T3 (en) |
HU (1) | HUE045532T2 (en) |
MX (1) | MX2017009863A (en) |
MY (1) | MY197518A (en) |
PH (1) | PH12017501336A1 (en) |
PL (1) | PL3120852T3 (en) |
PT (1) | PT3120852T (en) |
RU (1) | RU2705154C2 (en) |
SG (1) | SG11201704430SA (en) |
TR (1) | TR201910158T4 (en) |
TW (1) | TWI638817B (en) |
WO (1) | WO2016121953A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3115365T3 (en) | 2015-01-30 | 2018-05-28 | Taiho Pharmaceutical Co Ltd | HIS UNKNOWN SALT OF CONDENSED PYRIMIDIDE COMPOUND AND CRYSTALS THEREOF |
EP4079306A4 (en) * | 2019-12-19 | 2024-01-10 | Taiho Pharmaceutical Co Ltd | Therapeutic agent containing fused pyrimidine compound as active ingredient |
CN112209894B (en) * | 2020-10-23 | 2023-06-06 | 贵州医科大学 | 5-aryl substituted 2-aminobenzoxazole derivative, preparation method and application thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070135387A1 (en) | 2005-12-08 | 2007-06-14 | Michaelides Michael R | Inhibitors of protein kinases |
ATE522216T1 (en) * | 2006-09-13 | 2011-09-15 | Takeda Pharmaceutical | USE OF 2-6-(3-AMINE-PIPERIDINE-1-YL)-3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDINE-1-YLMETHYL-4-FLUORO-BENZONITRILE FOR THE TREATMENT OF DIABETES, CANCER, AUTOIMMUNE DISEASES AND HIV INFECTIONS |
WO2008054827A2 (en) * | 2006-11-03 | 2008-05-08 | Pharmacyclics, Inc. | Bruton's tyrosine kinase activity probe and method of using |
JP2009235057A (en) * | 2007-10-31 | 2009-10-15 | Santen Pharmaceut Co Ltd | New indole derivative having anti-angiogenesis activity |
TWI546290B (en) | 2008-06-27 | 2016-08-21 | 賽基艾維洛米斯研究股份有限公司 | Heteroaryl compounds and uses thereof |
US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
BR112014000653A2 (en) * | 2011-07-13 | 2017-02-14 | Pharmacyclics Inc | bruton tyrosine kinase inhibitors |
MX351513B (en) * | 2012-01-19 | 2017-10-17 | Taiho Pharmaceutical Co Ltd | 3,5-disubstituted alkynylbenzene compound and salt thereof. |
EP2890691B1 (en) * | 2012-08-31 | 2018-04-25 | Principia Biopharma Inc. | Benzimidazole derivatives as itk inhibitors |
CN105452257B (en) | 2013-08-12 | 2017-09-05 | 大鹏药品工业株式会社 | Novel fused pyrimidine compound or its salt |
-
2016
- 2016-01-29 BR BR112017016278-4A patent/BR112017016278B1/en active IP Right Grant
- 2016-01-29 AU AU2016213030A patent/AU2016213030B2/en active Active
- 2016-01-29 RU RU2017127126A patent/RU2705154C2/en active
- 2016-01-29 PL PL16743556T patent/PL3120852T3/en unknown
- 2016-01-29 HU HUE16743556A patent/HUE045532T2/en unknown
- 2016-01-29 CN CN202111054911.9A patent/CN113768935A/en active Pending
- 2016-01-29 WO PCT/JP2016/052732 patent/WO2016121953A1/en active Application Filing
- 2016-01-29 CN CN201680007390.2A patent/CN107206001B/en active Active
- 2016-01-29 TR TR2019/10158T patent/TR201910158T4/en unknown
- 2016-01-29 ES ES16743556T patent/ES2734364T3/en active Active
- 2016-01-29 SG SG11201704430SA patent/SG11201704430SA/en unknown
- 2016-01-29 EP EP16743556.9A patent/EP3120852B1/en active Active
- 2016-01-29 MX MX2017009863A patent/MX2017009863A/en unknown
- 2016-01-29 CA CA2975372A patent/CA2975372C/en active Active
- 2016-01-29 DK DK16743556.9T patent/DK3120852T3/en active
- 2016-01-29 PT PT16743556T patent/PT3120852T/en unknown
- 2016-01-29 MY MYPI2017701813A patent/MY197518A/en unknown
- 2016-01-29 KR KR1020177018431A patent/KR101858421B1/en active IP Right Grant
- 2016-01-29 TW TW105102962A patent/TWI638817B/en active
- 2016-01-29 JP JP2016533731A patent/JP6093485B2/en active Active
- 2016-10-19 US US15/297,196 patent/US9782412B2/en active Active
-
2017
- 2017-07-24 PH PH12017501336A patent/PH12017501336A1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL277648A (en) | Therapeutic microbiota for the treatment and/or prevention of food allergy | |
HK1252873A1 (en) | Vaccines for treatment and prevention of cancer | |
IL258854A (en) | Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer | |
ZA201902090B (en) | Combination treatments comprising administration of imidazopyrazinones | |
SG10201402819WA (en) | Composition for prevention and treatment of joint pain and the method of preparation thereof | |
IL266047A (en) | Methods and compositions for the treatment of fabry disease | |
IL247368A0 (en) | Diagnostic and therapeutic uses of exosomes | |
IL266486A (en) | Pharmaceutical compositions and methods for the treatment of cancer | |
HK1246689A1 (en) | Fixed dose combination of bromonidine and timolol | |
IL259710A (en) | Compositions and methods of treatment for mvid and related diseases | |
PT3081228T (en) | Irisin for care and prevention of osteoporosis | |
GB201504387D0 (en) | Materials and methods for the treatment of vascular disease | |
HK1258056A1 (en) | Therapeutic compounds and methods of use thereof | |
SG11201704430SA (en) | Preventive and/or therapeutic agent of immune disease | |
ZA201906964B (en) | Prevention and/or treatment of inflammatory skin disease | |
GB201522329D0 (en) | Use of adjuvants for the prevention and/or treatment of autoimmune diseases | |
PL3137097T3 (en) | Treatment and prevention of alzheimer's disease (ad) | |
HK1246271A1 (en) | Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treatment of diseases | |
EP3377062C0 (en) | Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases | |
LT3137093T (en) | Treatment and prevention of alzheimer`s disease (ad) | |
PT3137094T (en) | Treatment and prevention of alzheimer's disease (ad) | |
IL257689A (en) | Pharmaceutical compositions and methods for the treatment of hypoxia-related diseases | |
IL259383A (en) | Compound for use in the prevention and treatment of neurodegenerative diseases | |
GB201621398D0 (en) | Treatment of emt-associated disease | |
GB201522828D0 (en) | Prevention and treatment of glaucoma |